- Home
- SCLXW vs DSYWW Comparison
SCLXW vs DSYWW Comparison
Compare SCLXW & DSYWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- DSYWW
- Stock Information
- Founded
- SCLXW N/A
- DSYWW N/A
- Country
- SCLXW United States
- DSYWW China
- Employees
- SCLXW N/A
- DSYWW 50
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- DSYWW
- Sector
- SCLXW Health Care
- DSYWW
- Exchange
- SCLXW Nasdaq
- DSYWW Nasdaq
- Market Cap
- SCLXW N/A
- DSYWW N/A
- IPO Year
- SCLXW N/A
- DSYWW N/A
- Fundamental
- Price
- SCLXW $0.11
- DSYWW $0.03
- Analyst Decision
- SCLXW
- DSYWW
- Analyst Count
- SCLXW 0
- DSYWW 0
- Target Price
- SCLXW N/A
- DSYWW N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- DSYWW N/A
- Earning Date
- SCLXW 03-07-2025
- DSYWW N/A
- Dividend Yield
- SCLXW N/A
- DSYWW N/A
- EPS Growth
- SCLXW N/A
- DSYWW N/A
- EPS
- SCLXW N/A
- DSYWW N/A
- Revenue
- SCLXW $55,152,000.00
- DSYWW N/A
- Revenue This Year
- SCLXW N/A
- DSYWW N/A
- Revenue Next Year
- SCLXW N/A
- DSYWW N/A
- P/E Ratio
- SCLXW N/A
- DSYWW N/A
- Revenue Growth
- SCLXW 22.02
- DSYWW N/A
- 52 Week Low
- SCLXW $0.18
- DSYWW N/A
- 52 Week High
- SCLXW $0.18
- DSYWW N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- DSYWW N/A
- Support Level
- SCLXW N/A
- DSYWW N/A
- Resistance Level
- SCLXW N/A
- DSYWW N/A
- Average True Range (ATR)
- SCLXW 0.00
- DSYWW 0.00
- MACD
- SCLXW 0.00
- DSYWW 0.00
- Stochastic Oscillator
- SCLXW 0.00
- DSYWW 0.00
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About DSYWW Big Tree Cloud Holdings Limited
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.